Find out how health reform affects you.
Concussions are a major health concern in Colorado, especially among high school athletes. Now new research has found that...
CBS Local Health News
Members of Colorado’s health exchange board are concerned people will face a January gap in coverage if they don’t find out in time whether they’re eligible for Medicaid or other subsidies before their policies expire.
Those who study aging say we should prepare for a big increase in those who suffer from dementia. With older people living longer it could be a burden on caregivers.
Christmas came early for one very deserving little boy from Broomfield.
Dr. Dave Hnida's Blog
After yet another injury, Wes Welker has entered the mystery world of concussion management. By all indications, he should be on the no-play list this week. CBS4 Medical Editor Dr. Dave Hnida explains the NFL guidelines for concussions as well as the forms and checklists used by doctors to make decisions.
The little blue pill has been around for awhile, and as time goes on, more and more medical uses are being found for it. CBS4 Medical Editor Dr Dave Hnida reports how a drug for “E.D.” in men may provide relief for painful menstrual periods in women.
It’s a relatively common and simple problem, yet more than half of us self-treat the wrong way. As we head to frigid temps, Dr. Dave Hnida reports on a new study that looks at one of the most frequent of winter problems: nosebleeds. His advice: don’t take them lying down.
Thanksgiving is traditionally the start of the holiday season. It’s also tradionally the start of food poisoning season. CBS4 Medical Editor Dr Dave Hnida reports on how the “2-2-4″ rule may help make today—and the rest of the holidays– more enjoyable.
Millions of Americans take a daily aspirin to lessen the risk of a heart attack. But as CBS4 Medical Editor Dr. Dave Hnida reports, when you pop an aspirin can make a big difference in how much protection you truly get.
WebMD Health News
For parents, childhood vaccines are a source of reassurance, but also anxiety about side effects and reactions.
The FDA is continuing to investigate a possible link between the multiple sclerosis drug Gilenya.
Of the 7.5 million people with psoriasis, about 10 percent to 30 percent get psoriatic arthritis.